Tuesday, June 10, 2014

Low T Cases Consolidated Into MDL


The U.S. Judicial Panel on Multidistrict Litigation (JPML) has ordered all product liability lawsuits filed in U.S. District Courts nationwide involving injuries associated with the use of any testosterone replacement therapy (TRT) to be centralized before one judge in the Northern District of Illinois as part of an MDL, or multidistrict litigation.

Following oral arguments late last month in Dallas, Texas, the JPML issued an order on June 6, which transfers cases involving any “Low T” drugs to U.S. District Judge Matthew F. Kennelly for coordinated handling during pretrial proceedings.

Testosterone is a hormone that promotes the growth of the male reproductive system, contributes to proper sexual function, boosts libido, prevents loss of scalp hair and can reduce the accumulation of abdominal fat.Treatment is often prescribed to men in order to counteract the age-related decline in the hormone. It helps improve sex drive, bone density and muscle mass. But the benefits and risks of the long-term use of testosterone therapy are not well known. Testosterone therapy is most often administered as a gel, patch or injection.

There are approximately 45 filed Low T lawsuits in Federal districts throughout the country. Major side effects claimed in these lawsuits include stroke, heart attack or even death. Use of the medication has been linked to certain other risks, including heart problems, sleep apnea, high red blood cell production, skin reactions, breast enlargement and lower sperm production.

The following products treat low testosterone:
  • Androgel
  • Androderm
  • Axirom
  • Bio-T-Gel
  • Delatestryl
  • Depo-Testosterone
  • Fortesta
  • Striant
  • Testim
  • Testopel

The U.S. Food and Drug Administration (FDA) is investigating the risk of stroke, heart attack, and death in men taking FDA-approved testosterone products. It has been monitoring this risk and decided to reassess this safety issue based on the recent publication of two separate studies that each suggested an increased risk of cardiovascular events among groups of men prescribed testosterone therapy.

Pittman, Dutton & Hellums, P.C., is currently investigating Low T Therapy claims. If you or a loved one were prescribed testosterone therapy and were injured as a result, please contact Booth Samuels at 1-866-515-8880 or by email at booths@pittmandutton.com.



Blog Archive